New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 16, 2014
09:13 EDTABTAbbott sees accelerating sales growth in 2H14
The company expects to achieve double digit EPS growth this year despite reporting an unfavorable Exchange impact of 3% on sales in Q1. The company said it is "right on track" with the sales progression it expected in January with sales growth before exchange essentially the same as its planned forecast. Abbott expects continued momentum in Established Pharmaceuticals, particularly in Brazil and India. It sees continued in improvement in growth rate with emerging markets becoming a larger component of the business. Expects double sales growth and operating margin for Nutrition in 2H14. Comments taken from Q1 earnings conference call.
News For ABT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
07:41 EDTABTEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
09:06 EDTABTAbbott and Sekisui announce collaboration for coagulation testing
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots. Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use